title: [Anti-meningococcal vaccines].
abstract: Current anti-meningococcal vaccines are prepared from capsular saccharides (plain or conjugate). They target four serogroups A, C, Y and W135. No vaccine is available against serogroup B saccharide. However, protein-based vaccines (recombinant vaccines or outer membrane vesicle vaccines) allow developing vaccines against serogroup B isolates.
authors.affiliation: Institut Pasteur, unité des Neisseria, Centre national de référence des mẃningocoques, 75724 Paris Cedex 15, France. mktaha@pasteur.fr
authors.forename: Muhamed-Kheir
authors.initials: MK
authors.lastname: Taha
authors.forename: Jean-Michel
authors.initials: JM
authors.lastname: Alonso
mesh_terms: D015195:Drug Design; D006801:Humans; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D009345:Neisseria meningitidis / Q000276:immunology*; D012703:Serotyping
chemical_list: D022401:Meningococcal Vaccines